Comparison of proteins expressed by Pseudomonas aeruginosa strains representing initial and chronic isolates from a cystic fibrosis patient: an analysis by 2-D gel electrophoresis and capillary column liquid chromatography–tandem mass spectrometry
Isolates of Pseudomonas aeruginosa from chronic lung infections in cystic fibrosis (CF) patients have phenotypes distinct from those initially infecting CF patients, as well as from other clinical or environmental isolates. To gain a better understanding of the differences in these isolates, protein expression was followed using two-dimensional (2-D) gel electrophoresis and protein identification by peptide sequencing using micro-capillary column liquid chromatography–tandem mass spectrometry (μLC/MS/MS). The isolates selected for this analysis were from the sputum of a CF patient: strain 383 had a nonmucoid phenotype typical of isolates from the environment, and strain 2192, obtained from the same patient, had a mucoid phenotype typical of isolates from chronic CF lung infections. Strains 383 and 2192 were confirmed to be genetically identical by restriction endonuclease analysis, random amplified polymorphic DNA-PCR, and pulsed-field gel electrophoresis. Conditions of protein extraction were optimized for consistent high-resolution separation of several hundred proteins from these clinical isolates as detected by Coomassie staining of 2-D gels. Fourteen proteins were selected for analysis; this group included those whose expression was common between both strains as well as unique for each strain. The proteins were identified by μLC/MS/MS of the peptides produced by an in-gel tryptic digestion and compared to translated data from the Pseudomonas Genome Project; optimization of this technique has allowed for the comparison of proteins expressed by strains 383 and 2192.
BellA., BainsM., HancockR. E.1991; Pseudomonas aeruginosa outer membrane protein OprH: expression from the cloned gene and function in EDTA and gentamicin resistance. J Bacteriol 173:6657–6664
BiniL., Sanchez-CampilloM., SantucciA.9 other authors1996; Mapping of Chlamydia trachomatis proteins by immobiline-polyacrylamide two-dimensional electrophoresis: spot identification by N-terminal sequencing and immunoblotting. Electrophoresis 17:185–190[CrossRef]
BrownS. M., HowellM. L., VasilM. L., AndersonA. J., HassettD. J.1995; Cloning and characterization of the katB gene of Pseudomonas aeruginosa encoding a hydrogen peroxide-inducible catalase: purification of KatB, cellular localization, and demonstration that it is essential for optimal resistance to hydrogen peroxide. J Bacteriol 177:6536–6544
ChuL., MayT. B., ChakrabartyA. M., MisraT. K.1991; Nucleotide sequence and expression of the algE gene involved in alginate biosynthesis by Pseudomonas aeruginosa. Gene 107:1–10[CrossRef]
CordwellS. J., NouwensA. S., VerrillsN. M., McPhersonJ. C., HainsP. G., Van DykD. D., WalshB. D.1999; The microbial proteome database – an automated laboratory catalogue for monitoring protein expression in bacteria. . Electrophoresis 20:3580–3588[CrossRef]
DeanC. R., FranklundC. V., RetiefJ. D., CoyneJ. M. J., HatanoK., EvansD. J., PierG. B., GoldbergJ. B.1999; Characterization of the serogroup O11 O-antigen locus of Pseudomonas aeruginosa PA103. J Bacteriol 181:4275–4284
FoldersJ., TommassenJ., Van LoonL. C., BitterW.2000; Identification of a chitin-binding protein secreted by Pseudomonas aeruginosa. J Bacteriol 182:1257–1263[CrossRef]
GoldbergJ. B., OhmanD. E.1987; Construction and characterization of Pseudomonas aeruginosa algB mutants: role of algB in high-level production of alginate. J Bacteriol 169:1593–1602
GovanJ. R. W., DereticV.1996; Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 60:539–574
GrabertE., WingenderJ., WinklerU. K.1990; An outer membrane protein characteristic of mucoid strains of Pseudomonas aeruginosa. FEMS Microbiol Lett 68:83–88[CrossRef]
HancockR. E. W., NikaidoH.1978; Outer membranes of Gram-negative bacteria. XIX. Isolation from Pseudomonas aeruginosa PAO1 and use in reconstitution and definition of the permeability barrier. J Bacteriol 136:381–390
HancockR. E. W., MuthariaL. M., ChanL., DarveauR. P., SpeertD. P., PierG. B.1983; Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains. Infect Immun 42:170–177
HassettD. J., WoodruffW. A., WozniakD. J., VasilM. L., CohenM. S., OhmanD. E.1993; Cloning and characterization of the Pseudomonas aeruginosa sodA and sodB genes encoding manganese- and iron-cofactored superoxide dismutase: demonstration of increased manganese superoxide dismutase activity in alginate-producing bacteria. J Bacteriol 175:7658–7665
HassettD. J., SchweizerH. P., OhmanD. E.1995; Pseudomonas aeruginosa sodA and sodB mutants defective in manganese- and iron-cofactored superoxide dismutase activity demonstrate the importance of the iron-cofactored form in aerobic metabolism. J Bacteriol 177:6330–6337
KellyN. M., MacDonaldM. H., MartinN., NicasT., HancockR. E. W.1990; Comparion of the outer membrane protein and lipopolysaccharide profiles of mucoid and nonmucoid Pseudomonas aeruginosa. . J Clin Microbiol 28:2017–2021
KropinskiA. M., ChanL. C., MilazzoF. H.1979; The extraction and analysis of lipopolysaccharides from Pseudomonas aeruginosa strain PAO, and three rough mutants. Can J Microbiol 25:390–398[CrossRef]
MahenthiralingamE., CampbellM. E., FosterJ., LamJ. S., SpeertD. P.1996; Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis. J Clin Microbiol 34:1129–1135
MaherW. E., KobeM., FassR. J.1993; Restriction endonuclease analysis of clinical Pseudomonas aeruginosa strains: useful epidemiologic data from a simple and rapid method. J Clin Microbiol 31:1426–1429
MandalA., Naaby-HansenS., WolkowiczM. J.9 other authors1999; FSP95, a testis-specific 95-kilodalton fibrous sheath antigen that undergoes tyrosine phosphorylation in capacitated human spermatozoa. Biol Reprod 61:1184–1197[CrossRef]
MartinN. L., RawlingE. G., WongR. S. Y., RosokM., HancockR. E. W.1993; Conservation of surface epitopes in Pseudomonas aeruginosa outer membrane porin protein OprF. FEMS Microbiol Lett 113:261–266[CrossRef]
MatheeK., CiofuO., SternbergC.9 other authors1999; Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung. Microbiology 145:1349–1357[CrossRef]
MehtaA., KinterM. T., ShermanN. E., DriscollD. M.2000; Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA. Mol Cell Biol 20:1846–1854[CrossRef]
OhmanD. E., ChakrabartyA. M.1982; Utilization of human respiratory secretions by mucoid Pseudomonas aeruginosa of cystic fibrosis origin. Infect Immun 37:662–669
PollackM.2000; Pseudomonas aeruginosa. In Principles and Practice of Infectious Diseases pp. 2310–2335Edited byMandellG. L., BennettJ. E., DolinR. Philadelphia: Churchill Livingstone;
QuadroniM., JamesP., Dainese-HattP., KerteszM. A.1999; Proteome mapping, mass spectrometric sequencing and reverse transcription-PCR for characterization of the sulfate starvation-induced response in Pseudomonas aeruginosa PAO1. Eur J Biochem 266:986–996[CrossRef]
RawlingE. G., BrinkmanF. S. L., HancockR. E. W.1998; Roles of the carboxy-terminal half of Pseudomonas aeruginosa major outer membrane protein OprF in cell shape, growth in low-osmolarity medium, and peptidoglycan association. J Bacteriol 180:3556–3562
RehmB. H. A., GrabertE., HeinJ., WinklerU. K.1994; Antibody response of rabbits and cystic fibosis patients to an alginate-specific outer membrane protein of a mucoid strain of Pseudomonas aeruginosa. . Microb Pathog 16:43–51[CrossRef]
SchmidtK. D., TümmlerB., RömlingU.1996; Comparative genome mapping of Pseudomonas aeruginosa PAO with P. aeruginosa C, which belongs to a major clone in cystic fibrosis patients and aquatic habitats. J Bacteriol 178:85–93
SpeertD., CampbellM., PutermanM. L.11 other authors1994; A multicenter comparison of methods for typing strains of Pseudomonas aeruginosa predominantly from patients with cystic fibrosis. J Infect Dis 169:134–142[CrossRef]
SprottG. C., KovalS. F., SchnaitmanC. A.1994; Cell fractionation. In Methods for General and Molecular Bacteriology pp. 73–103Edited byGerhardtP., MurrayR. G. E., WoodW. A., KriegN. R. Washington, DC: American Society for Microbiology;
TombJ., WhiteO., KerlavageA. R.39 other authors1997; The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388:539–548[CrossRef]
Comparison of proteins expressed by Pseudomonas aeruginosa strains representing initial and chronic isolates from a cystic fibrosis patient: an analysis by 2-D gel electrophoresis and capillary column liquid chromatography–tandem mass spectrometry